Nordic Nanovector To Present At The Swiss-Scandinavian Bio-Business Seminar On 10 February 2016

OSLO, Norway--(BUSINESS WIRE)--Nordic Nanovector ASA (OSE: NANO), a company focusing on the development and commercialization of novel targeted therapeutics in haematology and oncology, announces that its CFO Tone Kvåle will present at the Swiss-Scandinavian Bio-Business seminar in Zurich, Switzerland on 10 February 2016. The slides of the presentation given will be available on the Nordic Nanovector website in the section: Investor Relations/Reports and Presentations/Presentations/2016. ###